Revised SPC: Verzenios (abemaciclib) film-coated tablets – all strengths

Section 4.2 provides information on dose interruption/dose reduction of abemaciclib in the event of adverse reactions such as interstitial lung disease/pneumonitis. Sections 4.4 and 4.8 have also been updated to reflect this.

Source:

electronic Medicines compendium